Martin Müller

Title: Martin Müller: Innovator in Immunogenic Polypeptides

Introduction

Martin Müller is a distinguished inventor based in Neckargemünd, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 6 patents to his name, Müller has focused on creating innovative solutions for preventing and treating infections.

Latest Patents

Müller's latest patents include groundbreaking work on combined prophylactic and therapeutic vaccines. This invention relates to an immunogenic polypeptide that comprises a B-cell epitope, a T-cell epitope, and a scaffold polypeptide, specifically a thioredoxin polypeptide. The invention aims to use this immunogenic polypeptide in medicine, particularly for treating and preventing inappropriate cell proliferation and infections, such as HPV. Another notable patent is the cutaneous papilloma virus vaccine, which involves an immunogenic polypeptide made up of multiple papillomavirus L2 N-terminal peptides. This invention is designed for use in vaccination against cutaneous and mucosal HPV infections.

Career Highlights

Throughout his career, Martin Müller has worked with reputable organizations, including the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the German Cancer Research Center Foundation of Public Law (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). His work has significantly advanced the understanding and treatment of viral infections.

Collaborations

Müller has collaborated with notable colleagues, including Xueer Zhao and Simone Ottonello. These partnerships have contributed to the success of his research and innovations in the field of immunology.

Conclusion

Martin Müller is a prominent inventor whose work in immunogenic polypeptides has the potential to revolutionize vaccine development. His contributions to the field are invaluable, and his patents reflect a commitment to advancing medical science.